These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9163612)

  • 1. Thrombopoietin-responsive essential thrombocythaemia with myelofibrosis.
    Ozaki S; Kosaka M; Ozaki K; Wakatsuki S; Hashimoto T; Miyazaki H
    Br J Haematol; 1997 May; 97(2):449-52. PubMed ID: 9163612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypersensitivity of megakaryocyte progenitors to thrombopoietin in essential thrombocythemia.
    Kawasaki H; Nakano T; Kohdera U; Kobayashi Y
    Am J Hematol; 2001 Nov; 68(3):194-7. PubMed ID: 11754402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased phospho-mTOR expression in megakaryocytic cells derived from CD34+ progenitors of essential thrombocythaemia and myelofibrosis patients.
    Vicari L; Martinetti D; Buccheri S; Colarossi C; Aiello E; Stagno F; Villari L; Cavalli M; Di Raimondo F; Gulisano M; De Maria R; Vigneri P
    Br J Haematol; 2012 Oct; 159(2):237-40. PubMed ID: 22924455
    [No Abstract]   [Full Text] [Related]  

  • 4. Spontaneous proliferative megakaryocytopoiesis and platelet hyperreactivity in essential thrombocythemia: is thrombopoietin the link?
    Bellucci S; Michiels JJ
    Ann Hematol; 2000 Feb; 79(2):51-8. PubMed ID: 10741915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocyte/macrophage dysfunctions do not impair the promotion of myelofibrosis by high levels of thrombopoietin.
    Wagner-Ballon O; Chagraoui H; Prina E; Tulliez M; Milon G; Raslova H; Villeval JL; Vainchenker W; Giraudier S
    J Immunol; 2006 Jun; 176(11):6425-33. PubMed ID: 16709799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous megakaryocytic colony formation and thrombopoietin sensitivity of megakaryocytic progenitor cells are useful to distinguish between essential thrombocythemia and reactive thrombocytosis.
    Mi JQ; Blanc-Jouvan F; Wang J; Sotto MF; Cousin F; Castinel A; Chauvet M; Sotto JJ; Polack B; Mossuz P
    J Hematother Stem Cell Res; 2001 Jun; 10(3):405-9. PubMed ID: 11454315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelofibrosis: experimental models and human studies.
    Taskin AL; Cohen-Solal K; Le Couedic JP; Abina MA; Villeval JL; Debili N; Casadevall N; Vainchenker W; Wendling F
    Stem Cells; 1998; 16 Suppl 2():155-64. PubMed ID: 11012187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GpIIb/IIIa+ subpopulation of rat megakaryocyte progenitor cells exhibits high responsiveness to human thrombopoietin.
    Kato T; Horie K; Hagiwara T; Maeda E; Tsumura H; Ohashi H; Miyazaki H
    Exp Hematol; 1996 Aug; 24(10):1209-14. PubMed ID: 8765496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombospondin-1 is not the major activator of TGF-β1 in thrombopoietin-induced myelofibrosis.
    Evrard S; Bluteau O; Tulliez M; Rameau P; Gonin P; Zetterberg E; Palmblad J; Bonnefoy A; Villeval JL; Vainchenker W; Giraudier S; Wagner-Ballon O
    Blood; 2011 Jan; 117(1):246-9. PubMed ID: 20944070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro autonomous growth of megakaryocytic progenitors and the role of thrombopoietin (Tpo) in essential thrombocythemia].
    Li Y; Brière J; Zhai M
    Zhonghua Xue Ye Xue Za Zhi; 2001 Jun; 22(6):300-2. PubMed ID: 11877088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extramedullary haematopoietic tumour of the breast: a case report in a woman with secondary myelofibrosis following essential thrombocythaemia.
    Al-Nafussi A; Al-Okati D; Alsewan M
    Histopathology; 2004 Jun; 44(6):625-6. PubMed ID: 15186279
    [No Abstract]   [Full Text] [Related]  

  • 12. A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand): reversal of disease by bone marrow transplantation.
    Yan XQ; Lacey D; Hill D; Chen Y; Fletcher F; Hawley RG; McNiece IK
    Blood; 1996 Jul; 88(2):402-9. PubMed ID: 8695786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of transforming growth factor-beta and thrombopoietin in the pathogenesis of myelodysplastic syndrome with myelofibrosis.
    Akiyama T; Matsunaga T; Terui T; Miyanishi K; Tanaka I; Sato T; Kuroda H; Takimoto R; Takayama T; Kato J; Yamauchi N; Kogawa K; Sakamaki S; Hirayama Y; Kohda K; Niitsu Y
    Leukemia; 2005 Sep; 19(9):1558-66. PubMed ID: 16034467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Megakaryocytes and platelets in myeloproliferative disorders.
    Briere J; Kiladjian JJ; Peynaud-Debayle E
    Baillieres Clin Haematol; 1997 Feb; 10(1):65-88. PubMed ID: 9154316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Megakaryocytes and myelofibrosis in gray platelet syndrome.
    Caen JP; Deschamps JF; Bodevin E; Bryckaert MC; Dupuy E; Wasteson A
    Nouv Rev Fr Hematol (1978); 1987; 29(2):109-14. PubMed ID: 3615193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential thrombocythemia: impaired regulation of megakaryocyte progenitors.
    Zauli G; Catani L; Gugliotta L; Gaggioli L; Vitale L; Belmonte MM; Aglietta M; Bagnara GP
    Int J Cell Cloning; 1991 Jan; 9(1):43-56. PubMed ID: 2010654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced responsiveness of bone marrow megakaryocyte progenitors to platelet-derived transforming growth factor beta 1, produced in normal amount, in patients with essential thrombocythaemia.
    Zauli G; Visani G; Catani L; Vianelli N; Gugliotta L; Capitani S
    Br J Haematol; 1993 Jan; 83(1):14-20. PubMed ID: 8435322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferative properties of human umbilical cord blood megakaryocyte progenitor cells to human thrombopoietin.
    Hagiwara T; Kodama I; Horie K; Kato T; Miyazaki H
    Exp Hematol; 1998 Mar; 26(3):228-35. PubMed ID: 9502619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative and functional studies of impaired natural killer (NK) cells in patients with myelofibrosis, essential thrombocythemia, and polycythemia vera. I. A potential role for platelet-derived growth factor in defective NK cytotoxicity.
    Gersuk GM; Carmel R; Pattamakom S; Challita PM; Rabinowitz AP; Pattengale PK
    Nat Immun; 1993; 12(3):136-51. PubMed ID: 8329837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of growth factor production in the mechanism of fibrosis in agnogenic myeloid metaplasia.
    Wang JC; Chang TH; Goldberg A; Novetsky AD; Lichter S; Lipton J
    Exp Hematol; 2006 Dec; 34(12):1617-23. PubMed ID: 17157157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.